Independent Arbitrator Imposes Public Reprimand on UFC Athlete Josh Barnett for Anti-Doping Policy Violation

published on 26 March 2018

Press Release

26th March 2018

USADA announced today that an independent arbitrator has rendered a decision in the case of UFC® athlete Josh Barnett, of Fullerton, Calif., and determined that Barnett should receive a public reprimand for his anti-doping policy violation. This decision comes after the facts of the case were fully briefed and presented at an evidentiary hearing on March 6, 2018.

Barnett, 40, tested positive for ostarine following an out-of-competition test conducted on December 9, 2016. Ostarine is a non-Specified Substance in the class of Anabolic Agents and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.

Ostarine, also known as MK-2866 and Enobosarm, is a non-FDA approved selective androgen receptor modulator (SARM) that is illegally sold in the United States and worldwide as a performance-enhancing substance. Ostarine is not currently available as a prescription medication in any country, and its unauthorized use may carry serious side effects. Nonetheless, ostarine has been found as a declared and undeclared ingredient in many dietary supplements sold in the United States, which has prompted the U.S. Food and Drug Administration (FDA) to issue warning letters (https://www.fda.gov/newsevents/newsroom/fdainbrief/ucm583021.htm) to specific dietary supplement manufacturers stating that ostarine is an unapproved new drug and that selling the drug is in violation of the Federal Food, Drug, and Cosmetic Act. More information about the risks of ostarine can be found through a USADA athlete advisory (https://ufc.usada.org/athlete-advisory-ostarine-supplements/).

Given the source was established to be a contaminated supplement, along with the athlete’s care and diligence concerning the nutritional products consumed, the arbitrator determined that a public reprimand was appropriate. The case was heard and the decision rendered by Richard H. McLaren, chief arbitrator from McLaren Global Sport Solutions, Inc. (MGSS), and can be found here, (https://ufc.usada.org/testing/results/arbitration-decisions/) along with all other UFC Anti-Doping Policy arbitral decisions.

USADA conducts the year-round, independent anti-doping program for all UFC athletes. USADA is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of clean athletes. In an effort to aid UFC athletes, as well as their support team members, in understanding the rules applicable to them, USADA provides comprehensive instruction on the UFC Anti-Doping Program website (https://ufc.usada.org/) regarding the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (https://ufc.globaldro.com/), conducts educational sessions, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, and periodic athlete alerts.

Views

1174

Leave a comment

Please login to leave a comment.

Official partners 

BASL
Soccerex Core Logo
SLA LOGO 1kpx
YRDA Logo2
SAC logo LawAccord

Copyright © LawInSport Limited 2010 - 2018. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.